World's Best Scientists 2026 revealed!
Silvio E. Inzucchi

Silvio E. Inzucchi

D-Index & Metrics

Medicine

D-Index
125
Citations
100071
World Ranking
3009
National Ranking
1664

Silvio E. Inzucchi publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Silvio E. Inzucchi sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 665 publications — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Silvio E. Inzucchi D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Silvio E. Inzucchi sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 125 D-Index — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Silvio E. Inzucchi is affiliated with Yale University in the United States. Their research primarily spans the field of Medicine, with a concentration in Endocrinology, Diabetes and Metabolism, as well as Cardiology and Cardiovascular Medicine. Other notable subfields include Surgery, Molecular Biology, and Pulmonary and Respiratory Medicine.

The main topics covered in their work include Diabetes Treatment and Management, Pancreatic Function and Diabetes, Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors, Metabolism, Diabetes and Cancer, Diabetes Management and Research, and Chronic Kidney Disease and Diabetes.

Some of their recent papers are:

  • Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction (2022) published in New England Journal of Medicine
  • Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease (2020) published in New England Journal of Medicine
  • Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials (2022) published in The Lancet
  • SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials (2022) published in The Lancet
  • Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes (2020) published in JAMA

Frequent co-authors in their collaborations include:

  • John J.V. McMurray
  • Mikhail Kosiborod
  • Scott D. Solomon
  • Pardeep S. Jhund
  • Felipe A. Martínez

Their publications have appeared repeatedly in high-profile venues, including:

  • Circulation (34 publications)
  • Journal of the American College of Cardiology (24 publications)
  • European Journal of Heart Failure (22 publications)
  • European Heart Journal (22 publications)
  • JACC Heart Failure (22 publications)

Silvio E. Inzucchi's research contributions focus heavily on the interplay of diabetes and cardiovascular conditions, especially in the context of treatment management involving sodium glucose co-transporter-2 (SGLT2) inhibitors. Their work also addresses the implications of diabetes on kidney outcomes and heart failure progression, reflecting interdisciplinary intersections between endocrinology, cardiology, and nephrology.

Best Publications

  • Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

    Bernard Zinman;Christoph Wanner;John M. Lachin;David Fitchett

  • Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

    John J.V. McMurray;Scott D. Solomon;Silvio E. Inzucchi;Lars Køber

  • Management of hyperglycemia in type 2 diabetes: A patient-centered approach: Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

    Silvio E. Inzucchi;Richard M. Bergenstal;John B. Buse;Michaela Diamant

  • Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

    Silvio E Inzucchi;Richard M Bergenstal;John B Buse;Michaela Diamant

  • Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

    Silvio E. Inzucchi;Richard M. Bergenstal;John B. Buse;Michaela Diamant

  • American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control.

    Etie S. Moghissi;Mary T. Korytkowski;Monica DiNardo;Daniel Einhorn

  • Oral Antihyperglycemic Therapy for Type 2 Diabetes: Scientific Review

    Silvio E. Inzucchi

  • Mechanism by which metformin reduces glucose production in type 2 diabetes.

    Ripudaman S. Hundal;Martin Krssak;Sylvie Dufour;Didier Laurent

  • Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379

    SE Inzucchi;RM Bergenstal;JB Buse;M Diamant

  • How Do We Define Cure of Diabetes

    John B. Buse;Sonia Caprio;William T. Cefalu;Antonio Ceriello

  • Pioglitazone after Ischemic Stroke or Transient Ischemic Attack

    W. N. Kernan;C. M. Viscoli;K. L. Furie;L. H. Young

  • Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.

    Silvio E. Inzucchi;David G. Maggs;Geralyn R. Spollett;Stephanie L. Page

  • Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study.

    Frans J Th Wackers;Lawrence H Young;Silvio E Inzucchi;Deborah A Chyun

  • Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial

    David Fitchett;Bernard Zinman;Bernard Zinman;Christoph Wanner;John M. Lachin

  • Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial.

    Lawrence H. Young;Frans J. Th. Wackers;Deborah A. Chyun;Janice A. Davey

  • Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes

    Ripudaman S. Hundal;Kitt F. Petersen;Adam B. Mayerson;Pritpal S. Randhawa

  • Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.

    Caroline S. Fox;Sherita Hill Golden;Cheryl Anderson;George A. Bray

  • Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes.

    Mikhail Kosiborod;Saif S. Rathore;Silvio E. Inzucchi;Frederick A. Masoudi

  • Erratum: Management of hyperglycaemia in type 2 diabetes: A patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (Diabetologia (2013) 56 (680))

    S. E. Inzucchi;R. M. Bergenstal;John B Buse;M. Diamant

  • Standards of Medical Care in Diabetes—2008: Response to Dora, Kramer, and Canani

    Irl B. Hirsch;Irl B. Hirsch;Silvio E. Inzucchi;Silvio E. Inzucchi;M. Sue Kirkman

Frequent Co-Authors

Mikhail Kosiborod
Mikhail Kosiborod University of Missouri–Kansas City
Christoph Wanner
Christoph Wanner University of Würzburg
Darren K. McGuire
Darren K. McGuire The University of Texas Southwestern Medical Center
Marc S. Sabatine
Marc S. Sabatine Brigham and Women's Hospital
Bernard Zinman
Bernard Zinman University of Toronto
Scott D. Solomon
Scott D. Solomon Brigham and Women's Hospital
Subodh Verma
Subodh Verma University of Toronto
Lars Køber
Lars Køber Copenhagen University Hospital
John J.V. McMurray
John J.V. McMurray University of Glasgow
Pardeep S. Jhund
Pardeep S. Jhund University of Glasgow

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees can provide flexible entry points and advancement opportunities in the healthcare sector. For registered nurses wanting to broaden their scope, asn to fnp programs offer a direct bridge from associate-level training to advanced nursing roles, preparing graduates for positions as Family Nurse Practitioners.

Those interested in specialized care or hospital management may consider pursuing an online mha programs cahme accredited. These programs help students develop leadership skills and business acumen for healthcare administration positions.

Many students seek science backgrounds before applying to medical school. If you have a particular interest in patient wellness or dietetics, earning one of the many online nutrition degrees can support careers in nutrition counseling or health education.

Finally, nurses aiming to advance without extensive in-person commitments can benefit from rn to bsn without clinicals. These programs enable RNs to earn higher credentials conveniently and flexibly, boosting employability and future study options.

Best Scientists Citing Silvio E. Inzucchi

Trending Scientists

Recently Published Articles